Clinical trial
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
NCT00415233 · University College, London, Other · Unknown status
Key facts
| NCT number | NCT00415233 |
|---|---|
| Title | High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer |
| Official title | Multicentre Randomised Trial of High Dose Versus Low Dose Radioiodine, With or Without Recombinant Human Thyroid Stimulating Hormone, for Remnant Ablation Following Surgery for Differentiated Thyroid Cancer [HILO] |
| Acronym | HiLo |
| Lead sponsor | University College, London, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Radiation |
| Interventions | recombinant thyroid-stimulating hormone, Radiodine ablation without rhTSH |
| Enrollment | 438 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2011 |
| Completion | Jul 1, 2025 |
| First posted | Dec 22, 2006 |
| Last update posted | Dec 19, 2023 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: